Canada markets closed

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
2.0300+0.0300 (+1.50%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 73.23M
Enterprise Value 71.64M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)48.36
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -10.48

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-69.24%
S&P500 52-Week Change 3-4.45%
52 Week High 38.1500
52 Week Low 31.6500
50-Day Moving Average 32.1164
200-Day Moving Average 34.0054

Share Statistics

Avg Vol (3 month) 310.18k
Avg Vol (10 day) 325.4k
Shares Outstanding 536.61M
Implied Shares Outstanding 6N/A
Float 834.43M
% Held by Insiders 15.99%
% Held by Institutions 10.00%
Shares Short (Jul 14, 2022) 41.87k
Short Ratio (Jul 14, 2022) 40.21
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.01%
Shares Short (prior month Jun 14, 2022) 44.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-98.80%
Return on Equity (ttm)-168.89%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-6.85M
Diluted EPS (ttm)-0.1950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.59M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.70
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-6.07M
Levered Free Cash Flow (ttm)-3.46M